Roche Venture Fund is a Basel, Switzerland based venture capital fund of Roche Holding founded in 2002.
The firm seeks to invest in life science companies in the pharmaceuticals and diagnostics sectors. The firm invests in early-stage and growth stages.
The notable investment portfolio of Roche Venture Fund includes Arch Oncology, Entrada Therapeutics, Freenome, Good Therapeutics, Jasper Therapeutics, MacuLogix, Minoryx Therapeutics, Biodesy, Purigen Biosystems, and Second Genome, etc.
As of January 2020, Roche Venture Fund has made 129 investments and had 67 exits.
Timeline
Funded Companies
A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.
Foundation Medicine is a Cambridge, Massachusetts-based pharmaceutical company developing diagnostic and treatment solutions and technologies for cancer care founded in 2010 by Alexis Borisy.
An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
Freenome is a San Francisco-based cancer screening company.
A company that offers gene editing, CRO and diagnostics services
A diagnostics company providing real-time biopsy material to guide personalized medicine for cancer patients
Maculogix is a Harrisburg, Pennsylvania-based diagnostics company focused on detection and tracking age-related macular degeneration.
Viracor-IBT Laboratories is a Lee's Summit, Missouri-based diagnostics laboratory specialized in allergy, immunology, and infectious disease testing.
MISSION Therapeutics is a Cambridge, Cambridgeshire-based biotechnology company offering a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes.
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.
Conatus Pharmaceuticals is a San Diego-based company.
A biopharmaceutical company developing stapled peptide therapeutics for the treatment of cancers and other diseases
A protein analysis company developing products and systems to analyze protein
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality
A biotechnology company developing medicines to treatment viral diseases
A company developing biologically active compounds and drug candidates
A company that develops therapeutic antibodies to treat diseases and allergies
A biotechnology company that develops RNA interference therapeutics
Arch Oncology is a Brisbane, California-based company.
People
Anja Harmeier
Investment Director
Carole Nuechterlein
Head Roche Venture Fund
David Evans
Investment Director
Gabriella Zöch
Project Associate
Karl Handelsman
Investment Director
Mitchell Mutz
Investment Director
Nisha Marathe
Investment Manager
Further reading
Documentaries, videos and podcasts
Companies
Arch Oncology
Biodesy
Entrada Therapeutics
Freenome
Good Therapeutics
Jasper Therapeutics
MacuLogix
Minoryx Therapeutics
Purigen Biosystems
Second Genome
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 2
Carla Faraguna
Golden People and Operations. - 3
Mevludin Mešanović
Bachelor of Electrical Engineering - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Henry Ogolla
Passionate about reading and writing. - 6
Aime Anne Nisay
QA Engineer of web and mobile applications